Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02ARA
|
|||
Former ID |
DNC004085
|
|||
Drug Name |
(1-Benzyl-1H-indol-5-yl)-quinazolin-4-yl-amine
|
|||
Synonyms |
CHEMBL287591; (1-Benzyl-1H-indol-5-yl)-quinazolin-4-yl-amine; SCHEMBL8554934; BDBM50099967
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C23H18N4
|
|||
Canonical SMILES |
C1=CC=C(C=C1)CN2C=CC3=C2C=CC(=C3)NC4=NC=NC5=CC=CC=C54
|
|||
InChI |
1S/C23H18N4/c1-2-6-17(7-3-1)15-27-13-12-18-14-19(10-11-22(18)27)26-23-20-8-4-5-9-21(20)24-16-25-23/h1-14,16H,15H2,(H,24,25,26)
|
|||
InChIKey |
HSEFNFDMTWKPLM-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 187667-74-9
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and C-erbB-2. Bioorg Med Chem Lett. 2001 Jun 4;11(11):1401-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.